NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
Fiche publication
Date publication
novembre 2016
Journal
Clinical journal of the American Society of Nephrology : CJASN
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH
Lien Pubmed
Résumé
Natriuretic peptides and echocardiographic parameters both predict cardiovascular events in patients with CKD. However, it is unknown whether simultaneous assessment of amino-terminal probrain natriuretic peptide (NT-proBNP) and echocardiographic parameters provides complementary or redundant predictive information; in the latter case, one of these two might be dispensable. We aimed to analyze the implications of using NT-proBNP alone, echocardiographic parameters alone, or a combination of both for prediction of adverse cardiovascular outcome.
Mots clés
Aged, Aged, 80 and over, Amputation, Cerebral Revascularization, Echocardiography, Female, Heart Atria, diagnostic imaging, Heart Failure, epidemiology, Humans, Hypertrophy, Left Ventricular, diagnostic imaging, Kaplan-Meier Estimate, Longitudinal Studies, Male, Middle Aged, Mortality, Myocardial Infarction, epidemiology, Myocardial Revascularization, Natriuretic Peptide, Brain, blood, Organ Size, Peptide Fragments, blood, Predictive Value of Tests, Prognosis, Prospective Studies, Renal Insufficiency, Chronic, blood, Risk Assessment, Severity of Illness Index, Stroke, epidemiology, Ventricular Dysfunction, Left, diagnostic imaging
Référence
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988